findmyKOL
Clinical trialNCT01257438CompletedInterventional

FLUENCY® PLUS Endovascular Stent Graft for In-stent Restenosis

SponsorC. R. BardEnrollment275Restenosis
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The primary purpose of this study is to demonstrate that the FLUENCY® PLUS Endovascular Stent Graft can effectively and safely treat in-stent restenotic lesions in the venous outflow of the Arteriovenous (AV) access circuit of hemodialysis patients with either of the two predominant vascular access types - those with an AV graft and those with an AV fistula.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Alabama Radiology Dept

    Birmingham, Alabama, United States

  • Arizona Kidney Disease & Hypertension Center-Surgery Center

    Phoenix, Arizona, United States

  • Southwest Kidney Institute Inc

    Phoenix, Arizona, United States

  • Capital Nephrology Access Center

    Sacramento, Arizona, United States

  • Angiocare Llc W/renal Care Associates Pc

    Tucson, Arizona, United States

  • Greater Long Beach Vascular Access Center

    Bellflower, California, United States

  • Ladenheim Dialysis Access Centers

    Fresno, California, United States

  • American Access Care Connecticut Image Guided Surgery

    Fairfield, Connecticut, United States

  • Yale University

    New Haven, Connecticut, United States

  • First Coast Cardiovascular Institute

    Jacksonville, Florida, United States

  • Vascular & Interventional Care Center

    Augusta, Georgia, United States

  • Savannah Vascular Surgery

    Savannah, Georgia, United States

  • Makrismd, Llc, D/b/a Chicago Access Care

    Hinsdale, Illinois, United States

  • the Vascular Access Center

    West Springfield, Massachusetts, United States

  • Prohealth Care Associates Llp

    Lake Success, New York, United States

  • Capital Access Center

    Raleigh, North Carolina, United States

  • Cleveland Clinic Foundation

    Cleveland, Ohio, United States

  • Providence Access Care

    Providence, Rhode Island, United States

  • Premeire Vascular Access and Imaging Center

    Knoxsville, Tennessee, United States

  • Renal Associates, P.A. Research Division

    San Antonio, Texas, United States

  • American Access Care of Richmond

    Richmond, Virginia, United States

  • University of Wisconsin School of Medicine & Public Health

    Madison, Wisconsin, United States

  • Midwest Nephrology Associates Vascular Access Center

    Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Dec 2010
Primary completion
30 Nov 2013
Completion
31 Jan 2016
Last update posted
9 Jan 2017
Registered enrollment
275
Registry id
NCT01257438
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.